newsfilter
← Latest News
GlobeNewswire·

X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures

- Repayment of Existing Loan Facility Completed -- Strengthens Financial Flexibility with Access to Funding for Corporate and Commercial Activities - - Expect Completion of Enrollment in Phase 3 4WARD trial by Year-End